SequelSEC

VIVOS INC RDGL

Surgical & Medical Instruments & Apparatus · CIK 0001449349 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$68.38K
Fiscal year ended 2025-12-31
Operating income
-$3.17M
Fiscal year ended 2025-12-31
Free cash flow
-$2.16M
Fiscal year ended 2025-12-31

VIVOS INC (RDGL) reported revenue of $68.38K and net income of -$3.07M for the fiscal year ended 2025-12-31. This page shows 8 annual periods of income statement, balance sheet and cash flow figures normalized from VIVOS INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

VIVOS INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312017-12-31
Revenue$68.38K$28.00K$19.50K$36.50K$14.89K$7.00K$9.50K$4.05K
Cost of revenue$128.13K$30.98K$25.54K$28.78K$12.00K$5.61K$6.03KUnavailable
Gross profit-$59.76K-$2.98K-$6.04K$7.72K$2.89K$1.39K$3.47KUnavailable
Operating income-$3.17M-$2.60M-$2.79M-$2.52M-$2.50M-$672.52K-$1.33M-$2.62M
Net income-$3.07M-$2.91M-$2.89M-$2.47M-$2.53M-$956.99K-$1.61M-$6.42M
Research & development$352.23K$324.63K$732.70K$343.80K$286.85K$84.67K$67.58K$203.04K
Weighted-average diluted sharesshares 452.72Mshares 409.67Mshares 368.81Mshares 351.43MUnavailableUnavailableUnavailableUnavailable
Pretax income-$3.07M-$2.91M-$2.89M-$2.47M-$2.53M-$956.99K-$1.61M-$6.42M
Income tax expenseUnavailableUnavailableUnavailableUnavailable$0$0UnavailableUnavailable
Diluted EPS$-0.01$-0.01$-0.01$-0.01UnavailableUnavailableUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$221.12K
General & administrative$296.56K$241.82K$165.77K$151.11K$112.04K$109.03K$74.33K$109.46K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$111.66K

Balance

VIVOS INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312017-12-31
Cash & equivalentsUnavailable$2.21M$1.59M$1.71M$1.61M$903.70K$20.38K$8.32K
Total assets$1.87M$2.23M$1.61M$1.74M$1.63M$937.54K$43.87K$15.70K
Current assets$1.65M$2.23M$1.61M$1.74M$1.63M$937.54K$43.87K$15.03K
Total liabilities$206.74K$86.21K$245.00K$81.69K$166.92K$905.50K$1.52M$4.28M
Current liabilities$117.89K$86.21K$245.00K$81.69K$166.92K$905.50K$1.52M$4.28M
Total equity incl. NCI$1.66M$2.15M$1.37M$1.66M$1.47M$32.03K-$1.48M-$4.26M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$57.26KUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$8.48K
Accounts receivable$22.33K$10.33K$7.00K$11.00KUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

VIVOS INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312017-12-31
Operating cash flow-$2.06M-$1.68M-$1.29M-$1.12M-$963.82K-$875.81K-$837.11K-$1.29M
Capital expenditures$103.18KUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow-$103.18KUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$2.80K
Financing cash flow$1.51M$2.30M$1.18M$1.22M$1.67M$1.76M$852.00K$1.27M
Net change in cash-$654.02K$620.26K-$113.78K$99.94K$702.42K$883.32K$14.89K-$19.57K
Stock-based compensationUnavailableUnavailableUnavailableUnavailable$1.61M$2.18K$608.59K$103.86K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$1.47K

Derived

VIVOS INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312017-12-31
Free cash flow-$2.16MUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin-87.4%-10.7%-31.0%21.2%19.4%19.9%36.5%Unavailable
Operating margin-4628.7%-9303.0%-14323.8%-6898.1%-16805.3%-9607.4%-13999.8%-64551.4%
FCF margin-3160.2%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailable31.1%6406.2%2562.0%
Current ratio14.00x25.91x6.57x21.33x9.79x1.04x0.03x0.00x
Revenue YoY growth144.3%43.6%-46.6%145.2%112.7%-26.3%UnavailableUnavailable
Net margin-4483.9%-10396.3%-14844.9%-6767.7%-16979.7%-13671.3%-16948.4%-158330.7%
R&D / revenue515.1%1159.6%3757.4%941.9%1926.8%1209.5%711.4%5008.3%
CapEx / revenue150.9%UnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open RDGL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-09View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.